Burgess, J, Marshall, A, Rapteas, L, Riley, D, Matsumoto, K, Boon, C, Alchawaf, A, Ferdousi, M, Malik, RA, Marshall, A, Kaye, ...
The following is a summary of “Experience Sampling Method in Small Fiber Neuropathy: The Influence of Psychosocial Factors on ...
Sangamo Therapeutics Inc. has received IND clearance from the FDA for ST-503, an investigational epigenetic regulator for the treatment of intractable pain due to idiopathic small fiber neuropathy ...
Sangamo Therapeutics said the Food and Drug Administration has cleared its investigational new drug application for its ST-400 treatment for intractable pain due to idiopathic small fiber neuropathy.
Shares of Sangamo Therapeutics (NASDAQ:SGMO) rose 12% in post-market trading Tuesday after the company announced the FDA had ...
Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...
Burgess, J, Marshall, A, Rapteas, L, Hamill, KJ, Marshall, A, Malik, RA, Frank, B and Alam, U (2024) Automated ...
Idiopathic Parkinson’s disease (IPD ... an association between peripheral neuropathy (PN) and IPD has been demonstrated in some of the rare genetic forms of Parkinson’s disease.